Walleye Capital
CRL icon

Walleye Capital’s Charles River Laboratories CRL Stock Holding History

Walleye Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345K Buy
+2,000
New +$371K ﹤0.01% 2956
2025
Q4 		– Sell
-1,000
Closed -$156K – 4645
2025
Q3 		$156K Sell
1,000
-1,200
-55% -$191K ﹤0.01% 3467
2025
Q2 		$334K Sell
2,200
-300
-12% -$40K ﹤0.01% 2972
2025
Q1 		$376K Sell
2,500
-1,800
-42% -$302K ﹤0.01% 2783
2024
Q4 		$794K Buy
4,300
+2,400
+126% +$462K ﹤0.01% 2585
2024
Q3 		$374K Buy
1,900
+1,000
+111% +$208K ﹤0.01% 3561
2024
Q2 		$186K Sell
900
-2,000
-69% -$453K ﹤0.01% 4356
2024
Q1 		$786K Sell
2,900
-2,000
-41% -$478K ﹤0.01% 2811
2023
Q4 		$1.16M Sell
4,900
-4,300
-47% -$846K ﹤0.01% 2227
2023
Q3 		$1.8M Sell
9,200
-7,200
-44% -$1.48M ﹤0.01% 1816
2023
Q2 		$3.45M Buy
16,400
+7,000
+74% +$1.39M 0.01% 963
2023
Q1 		$1.9M Buy
+9,400
New +$2.13M 0.03% 757
2022
Q4 		– Sell
-300
Closed -$59K – 3256
2022
Q3 		$59K Buy
+300
New +$64.8K ﹤0.01% 2555
2020
Q1 		– Sell
-3,600
Closed -$550K – 1055
2019
Q4 		$550K Sell
3,600
-7,400
-67% -$1.02M 0.04% 635
2019
Q3 		$1.46M Sell
11,000
-7,400
-40% -$992K 0.09% 314
2019
Q2 		$2.61M Buy
18,400
+7,800
+74% +$1.06M 0.29% 54
2019
Q1 		$1.54M Buy
+10,600
New +$1.39M 0.25% 76

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Walleye Capital's CRL Position: Q1 2026 in Review

Walleye Capital reduced its Charles River Laboratories (CRL) stake by 99% in Q1 2026, selling an estimated $46.2M and leaving 1,932 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

Walleye Capital first reported a position in CRL in Q1 2019 and has held it in 16 quarters since. The position peaked at $50.1M in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Walleye Capital held 1,932 shares of Charles River Laboratories worth $333K as of Q1 2026.
  • Walleye Capital sold 249,189 Charles River Laboratories shares in Q1 2026, an estimated $46.2M.
  • Charles River Laboratories made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2990 holding.
  • Walleye Capital first reported a position in Charles River Laboratories in Q1 2019 and has held it in 16 quarters since.
  • Walleye Capital's Charles River Laboratories position peaked at $50.1M in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.